// App-Quantinova.ai

OP0047 : GENOME-WIDE ASSOCIATION STUDY OF SJÖGREN’S SYNDROME IDENTIFIES TEN NEW RISK LOCI

Researchers

Presenter

  • B. Khatri

Principal Investigators

  • K. L. Tessneer

  • A. Rasmussen

  • R. H. Scofield

  • S. J. Bowman

  • J. Guthridge

  • J. A. James

  • L. Ronnblom

  • B. M. Warner

  • X. Mariette

  • R. Omdal

  • J. Martin Ibanez

  • M. Teruel

  • J. L. Jensen

  • L. A. Aqrawi

  • . Palm

  • M. Wahren-Herlenius

  • T. Witte

  • R. Jonsson

  • M. Rischmueller

  • A. D. Farris

  • M. Alarcon-Riquelme

  • W. F. Ng

  • K. L. Sivils

  • G. Nordmark

  • C. Lessard

Medical Centers

  • Oklahoma Medical Research Foundation, Oklahoma City, United States

  • University of Bergen, Bergen, Norway

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Uppsala University Hospital, Uppsala, Sweden

  • National Institute of Dental and Craniofacial Research (NIDCR), NIH, Bethesda, MD, United States of America

  • Universite Paris-Sud, Le Kremlin Bictre, France

  • University of Granada / Andalusian Regional Government,Granada ,Spain

  • University of Oslo, Oslo, Norway

  • Karolinska Institutet, Stockholm, Sweden

  • Hannover Medical School, Hannover, Germany

  • Haukeland University Hospital, Bergen, Norway

  • University of Adelaide, Adelaide, Australia

  • NHR Biomedical Research Centre, Newcastle Upon Tyne, United Kingdom

Locations

  • United States

  • Norway

  • United Kingdom

  • Sweden

  • France

  • Spain

  • Germany

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Sjogren's syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved